These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 27078884)
1. Nonselective inhibition of the epigenetic transcriptional regulator BET induces marked lymphoid and hematopoietic toxicity in mice. Lee DU; Katavolos P; Palanisamy G; Katewa A; Sioson C; Corpuz J; Pang J; DeMent K; Choo E; Ghilardi N; Diaz D; Danilenko DM Toxicol Appl Pharmacol; 2016 Jun; 300():47-54. PubMed ID: 27078884 [TBL] [Abstract][Full Text] [Related]
2. JQ1 affects BRD2-dependent and independent transcription regulation without disrupting H4-hyperacetylated chromatin states. Handoko L; Kaczkowski B; Hon CC; Lizio M; Wakamori M; Matsuda T; Ito T; Jeyamohan P; Sato Y; Sakamoto K; Yokoyama S; Kimura H; Minoda A; Umehara T Epigenetics; 2018; 13(4):410-431. PubMed ID: 30080437 [TBL] [Abstract][Full Text] [Related]
3. Bromodomain and extraterminal domain-containing protein inhibition attenuates acute inflammation after spinal cord injury. Rudman MD; Choi JS; Lee HE; Tan SK; Ayad NG; Lee JK Exp Neurol; 2018 Nov; 309():181-192. PubMed ID: 30134146 [TBL] [Abstract][Full Text] [Related]
4. Altered regulation and expression of genes by BET family of proteins in COPD patients. Malhotra R; Kurian N; Zhou XH; Jiang F; Monkley S; DeMicco A; Clausen IG; Dellgren G; Edenro G; Ahdesmäki MJ; Clausen M; Öberg L; Israelsson E; Belfield G; Vaarala O PLoS One; 2017; 12(3):e0173115. PubMed ID: 28248992 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of BET bromodomain targets genetically diverse glioblastoma. Cheng Z; Gong Y; Ma Y; Lu K; Lu X; Pierce LA; Thompson RC; Muller S; Knapp S; Wang J Clin Cancer Res; 2013 Apr; 19(7):1748-59. PubMed ID: 23403638 [TBL] [Abstract][Full Text] [Related]
7. Bromodomain inhibitors, JQ1 and I-BET 762, as potential therapies for pancreatic cancer. Leal AS; Williams CR; Royce DB; Pioli PA; Sporn MB; Liby KT Cancer Lett; 2017 May; 394():76-87. PubMed ID: 28254412 [TBL] [Abstract][Full Text] [Related]
8. BET Bromodomain Blockade Mitigates Intimal Hyperplasia in Rat Carotid Arteries. Wang B; Zhang M; Takayama T; Shi X; Roenneburg DA; Kent KC; Guo LW EBioMedicine; 2015 Nov; 2(11):1650-61. PubMed ID: 26870791 [TBL] [Abstract][Full Text] [Related]
9. Selective BET-bromodomain inhibition by JQ1 suppresses dendritic cell maturation and antigen-specific T-cell responses. Remke N; Bisht S; Oberbeck S; Nolting J; Brossart P Cancer Immunol Immunother; 2021 Jan; 70(1):107-121. PubMed ID: 32651619 [TBL] [Abstract][Full Text] [Related]
10. BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses. Belkina AC; Nikolajczyk BS; Denis GV J Immunol; 2013 Apr; 190(7):3670-8. PubMed ID: 23420887 [TBL] [Abstract][Full Text] [Related]
11. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma. Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725 [TBL] [Abstract][Full Text] [Related]
13. Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. Lambert JP; Picaud S; Fujisawa T; Hou H; Savitsky P; Uusküla-Reimand L; Gupta GD; Abdouni H; Lin ZY; Tucholska M; Knight JDR; Gonzalez-Badillo B; St-Denis N; Newman JA; Stucki M; Pelletier L; Bandeira N; Wilson MD; Filippakopoulos P; Gingras AC Mol Cell; 2019 Feb; 73(3):621-638.e17. PubMed ID: 30554943 [TBL] [Abstract][Full Text] [Related]
14. The Bromodomain and Extra-Terminal Domain (BET) Family: Functional Anatomy of BET Paralogous Proteins. Taniguchi Y Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27827996 [TBL] [Abstract][Full Text] [Related]
15. BET inhibitor JQ1 suppresses cell proliferation via inducing autophagy and activating LKB1/AMPK in bladder cancer cells. Li F; Yang C; Zhang HB; Ma J; Jia J; Tang X; Zeng J; Chong T; Wang X; He D; Guo P Cancer Med; 2019 Aug; 8(10):4792-4805. PubMed ID: 31250978 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic targeting of BET protein BRD4 delays murine lupus. Wei S; Sun Y; Sha H Int Immunopharmacol; 2015 Dec; 29(2):314-319. PubMed ID: 26590112 [TBL] [Abstract][Full Text] [Related]
17. Targeting STAT5 in hematologic malignancies through inhibition of the bromodomain and extra-terminal (BET) bromodomain protein BRD2. Liu S; Walker SR; Nelson EA; Cerulli R; Xiang M; Toniolo PA; Qi J; Stone RM; Wadleigh M; Bradner JE; Frank DA Mol Cancer Ther; 2014 May; 13(5):1194-205. PubMed ID: 24435449 [TBL] [Abstract][Full Text] [Related]
19. When are the BET factors the most sensitive to bromodomain inhibitors? Khochbin S Transcription; 2013; 4(2):54-7. PubMed ID: 23412362 [TBL] [Abstract][Full Text] [Related]
20. Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Aird F; Kandela I; Mantis C; Elife; 2017 Jan; 6():. PubMed ID: 28100400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]